Published On: May 26th, 2010
The company is currently enrolling 60 patients in Germany and Hungary for a trial comparing its biosimilar drug, TL011, with Rituxan, approved to treat rheumatoid arthritis and two kinds of cancer.

View post:
Teva Takes Another Step Into Biosimilars Market
STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.
Loading...
Did you know:
The rate of Hepatitis B HBV in Asian Americans is more than two times the rate of HBV in whites 2.95 versus 1.31 cases per 100,000
-
hikersheila : RT @FierceBiotech: #Pharma #VC embrace linked to a #biotech's chance of success http://t.co/mWarztIl #CVC $PFE $GSK $N http://t.co/hW6Qq8Rx2012-05-24T02:53:04Z - Reply - View Tweet
-
PrincessKiitty : @vivaaaye do u know if the biotech book is due tomorrow?2012-05-24T02:47:58Z - Reply - View Tweet
-
gardnerqx8 : XDx links with LabCorp in lupus license deal: XDx Inc. will work with? http://t.co/SoLeT7es BiotechSF blog2012-05-24T02:47:37Z - Reply - View Tweet
-
MasonAilstock : RT @TheRTP: RT @syngentabiotech @WorkTriangleNC we've over 20 #biotech #jobs for Smarty Pants who want 2 #workinthetriangle. http://t.co/55iUI8Ys2012-05-24T02:46:38Z - Reply - View Tweet
-
richardsrg : Biotech Crops Delivering Economic and Environmental Benefits - Hoosier Ag Today: Biotech Crops Delivering Econom... http://t.co/DyAgTWF62012-05-24T02:43:54Z - Reply - View Tweet
-
CM_SITE : ?????? ????? ??????96.1??(????????) : http://t.co/mHivDQP9 #ikumou #usuge #hage #AGA #followmejp2012-05-24T02:42:58Z - Reply - View Tweet
-
AJStein_de : #Biotechnology innovation for inclusive growth: Indian policies to foster #technology #adaptation for #development http://t.co/dmgz6OeN #GMO2012-05-24T02:39:48Z - Reply - View Tweet
Related Posts
- A.M. Vitals: J&J Aims to Step Into Blood-Thinner Market
Also: NFL players union rejects long-term care proposal; Novartis cuts lung-cancer drug; a surprising benefit of Tetris. .. - Another Cholesterol Drug to Join the U.S. Market
Who knew there would be another statin added to the crowded U.S. cholesterol-drug market? The FDA approved a new one yesterday .. - Sanofi to Dive Further into Generic Drug-Making Pool
Another large drug maker is poised to expand its generic medicine business. This time it’s French-based heavyweight Sanofi-Aventis that wants to sell more in generics, particularly in the faster-growing emerging markets, writes the WSJ . As part of this push, it recently bought two generic-drug companies in Latin America, and a Czech generics maker Zentiva.. - TV Docs Mix Media With Medicine in Haiti
You’re a TV correspondent on the scene in Haiti, reporting on the devastation following the Jan. 12 earthquake. But you’re also a doctor in the place where there’s an intense need for people to treat the injured .. - Gladwell Digs into Cancer Drug Research Difficulties
It’s unlikely that a “master code behind the disease” will ever be cracked, writes Gladwell. “Perhaps there is only what can be uncovered, one step at a time, through trial and error.” .. - Medco, Amgen Weigh in On Biosimilars at FDA Meeting
It’s not yet clear whether generic versions of large-molecule biologic drugs will have to undergo separate trials. ..
Leave a comment









